Phase I Dose Escalation Study of Sodium Stibogluconate (SSG), a Protein Tyrosine Phosphatase Inhibitor, Combined With Interferon Alpha for Patients With Solid Tumors

Journal of Cancer - Australia
doi 10.7150/jca.2.81

Related search